Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases
A Giannakogeorgou, M Roden - Alimentary Pharmacology & …, 2024 - Wiley Online Library
Background The current obesity pandemic has given rise to associated comorbidities and
complications, including type 2 diabetes and metabolic dysfunction‐associated steatotic …
complications, including type 2 diabetes and metabolic dysfunction‐associated steatotic …
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
JC Locatelli, JG Costa, A Haynes, LH Naylor… - Diabetes …, 2024 - Am Diabetes Assoc
This narrative review highlights the degree to which new antiobesity medications based on
gut-derived nutrient-stimulated hormones (incretins) cause loss of lean mass, and the …
gut-derived nutrient-stimulated hormones (incretins) cause loss of lean mass, and the …
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels
S Capuccio, S Scilletta, F La Rocca, N Miano… - Biomolecules, 2024 - mdpi.com
The increasing utilization of Glucagon-like Peptide-1 receptor agonists (GLP-1 RAs) in
managing type 2 diabetes mellitus has raised interest regarding their impact on thyroid …
managing type 2 diabetes mellitus has raised interest regarding their impact on thyroid …
[HTML][HTML] Fasting and post prandial pancreatic and enteroendocrine hormone levels in obese and non-obese participants
Circulating insulin levels are known to be increased in people with higher body mass index
(BMI) due to effects of adiposity on insulin resistance, whilst gut hormones have a more …
(BMI) due to effects of adiposity on insulin resistance, whilst gut hormones have a more …
Therapie des Typ-2-Diabetes
R Landgraf, J Aberle, AL Birkenfeld, B Gallwitz… - Die Diabetologie, 2024 - Springer
Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft (DDG) lehnen sich an die
Inhalte der Nationalen Versorgungs-Leitlinie (NVL) Typ-2-Diabetes an [1]. Die in den …
Inhalte der Nationalen Versorgungs-Leitlinie (NVL) Typ-2-Diabetes an [1]. Die in den …
[HTML][HTML] Type 2 Diabetes in Children and Adolescents-A Focus on Diagnosis and Treatment
O Pinhas-Hamiel, P Zeitler - 2023 - europepmc.org
Nearly three decades have passed since the first publications on type 2 diabetes (T2D) in
children and adolescents, and it is now well established as a global problem. As the …
children and adolescents, and it is now well established as a global problem. As the …
[PDF][PDF] Farmácia Barreiros, Porto e Serviços Farmacêuticos do Hospital das Forças Armadas-Polo Porto, Porto
APF do Vale - 2023 - repositorio-aberto.up.pt
O estágio curricular como última Unidade Curricular Obrigatória do Mestrado Integrado em
Ciências Farmacêuticas significa o culminar das aprendizagens para formar o profissional …
Ciências Farmacêuticas significa o culminar das aprendizagens para formar o profissional …
Which GLP1 receptor agonist approved for weight loss is the most effective at achieving weight loss?
A Abresch, T Aulakh, P Domingo, T Harris… - Evidence-Based …, 2024 - journals.lww.com
Tirzepatide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) and glucose-dependent
insulinotropic polypeptide agonist, is the most effective weight loss medication, followed in …
insulinotropic polypeptide agonist, is the most effective weight loss medication, followed in …
Therapy of Type 2 Diabetes
R Landgraf, J Aberle, AL Birkenfeld… - Experimental and …, 2024 - thieme-connect.com
Change 2: On the basis of current data, the various risk factors and their structured
assessment (including the increasing importance of fatty liver) for the development of …
assessment (including the increasing importance of fatty liver) for the development of …
Semaglutide Reduces Overconsumption of HFD in a Rodent Model of Binge Eating
J Guard - 2024 - diginole.lib.fsu.edu
Semaglutide (SEMA; marketed as Ozempic®) has been shown to decrease palatable food
intake, leading to weight loss, in individuals with obesity. Less is known about its ability to …
intake, leading to weight loss, in individuals with obesity. Less is known about its ability to …